Azithromycin, an azalide antibiotic, rarely causes ototoxicity. According to the few reports in existence, azithromycin-induced ototoxicity occurred following prolonged high-dose therapy in patients with acquired immunodeficiency syndrome and resulted in a reversible sensorineural hearing loss. We present a case of irreversible sensorineural hearing loss due to azithromycin ototoxicity in an otherwise healthy woman following low-dose exposure to azithromycin.
WallaceMRMillerLKNguyenMTShieldsAR. Ototoxicity with azithromycin [Letter]. Lancet1994; 343: 241.
2.
TsengALDolovichLSalitIE. Azithromycin-related ototoxicity in patients infected with human immunodeficiency virus. Clin Infect Dis1997; 24: 77–8.
3.
MintzUAmirJPinkhasJDeVriesA. Transient perceptive deafness after erythromycin. JAMA1973; 225: 1122–3.
4.
LevinGBehrenthE. Irreversible ototoxic effect of erythromycin. Scand Audiol1986; 15: 41–2.
5.
DylewskiJ. Irreversible sensorineural hearing loss due to erythromycin. Can Med Assoc J1988; 139: 230–1.
6.
HopkinsS. Clinical toleration and safety of azithromycin. Am J Med1991; 91(suppl 3A): 40S–45S.
7.
FeeW. Aminoglycoside ototoxicity in the human. Laryngoscope1980; 90(Suppl 24): 1–19.
8.
KomuneSAsakimaSSnowJB. Pathophysiology of the ototoxicity of cis-diammine-dichloroplatinum. Otolaryngol Head Neck Surg1981; 89: 275–82.
9.
PrezantTRAgapianJVBohlmanMC. Mitochondrial ribosomal RNA mutations associated with antibiotic and non-syndromic deafness. Nat Genet1993; 4: 289–94.
10.
RessBDBalkanyTJ. Audiovestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. (Commentary.) Otolaryngol J Club J1997; 4: 152–4.
11.
YamasobaTYoshimotoOKatsunoriTMasaichiNKimitakaK. Auditory findings in patients with maternally inherited diabetes and deafness harboring a point mutation in the mitochondrial transfer RNALeu(UUR) gene. Laryngoscope1996; 106: 49–53.
